Dominion Aesthetic Technologies, developers of EON - the touchless, intelligent body contouring device - has successfully closed Series B financing, raising a total of $23.7 million. Dominion Aesthetic Technologies' CEO, Cooper Collins, led the Series B round with support from Houston's top biotechnology and medical device investors, including MagnaSci Ventures, McNair Interests Ltd, and Morton Cohn Investments. Series B funding will accelerate the manufacturing and commercialization of EON as the leading innovator in the field of aesthetics.

Dominion Aesthetic Technologies is a medical device company and EON developer. For more information on Dominion Aesthetic Technologies, please visit www.dominionaesthetic.com or explore more about EON by visiting www.eonlaser.com.